Mikov, Momir

Мрежа сарадње Статистика Имејл упозорење RSS Feed

Publications

Резултати 121-140 од 152 (Време претраге: 0.004 секунди).

Датум издавањаНасловАутор(и)
12112-нов-2018Pharmacological effects of nanoencapsulation of human-based dosing of probucol on ratio of secondary to primary bile acids in gut, during induction and progression of type 1 diabetesMooranian A.; Zamani N.; Takechi R.; Al-Sallami H.; Momir Mikov ; Svetlana Goločorbin-Kon ; Božica Kovačević; Arfuso F.; Al-Salami H.
1225-јун-2020Pharmacological Effects of Secondary Bile Acid Microparticles in Diabetic Murine ModelArmin Mooranian; Nassim Zamani; Božica Kovačević; Corina Mihaela Ionescu; Giuseppe Luna; Momir Mikov ; Svetlana Goločorbin-Kon ; Goran Stojanović ; Sanja Kojić ; Hani Al-Salami
1231-јан-2006Pharmacology of bile acids and their derivatives: Absorption promoters and therapeutic agentsMikov, Momir ; Fawcett J.; Kuhajda K.; Kevresan S. 
1241-дец-2012Pleiotropic functions of bile acids mediated by the farnesoid X receptorStanimirov, Bojan ; Stankov, Karmen ; Mikov, Momir 
12516-окт-2021Polyelectrolytes Formulated with Primary Unconjugated Bile Acid Optimised Pharmacology of Bio-engineered ImplantArmin Mooranian; Corina Mihaela Ionescu; Susbin Raj Wagle; Božica Kovačević; Daniel Walker; Melissa Jones; Jacqueline Chester; Thomas Foster; Edan Johnston; Sanja Kojić ; Goran Stojanović ; Momir Mikov ; Hani Al-Salami
1261-јун-2018Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and ProbioticsMomir Mikov ; Maja Đanić ; Nebojša Pavlović ; Bojan Stanimirov ; Svetlana Goločorbin-Kon ; Karmen Stankov ; Hani Al-Salami
12717-сеп-2019Potentials of human bile acids and their salts in pharmaceutical nano delivery and formulations adjuvantsKecman, S; Škrbić R.; Alma Badnjević Čengić; Armin Mooranian; Hani Al-Salami; Momir Mikov ; Svetlana Goločorbin-Kon 
1281-дец-2012Probiotics - Interactions with Bile Acids and Impact on Cholesterol MetabolismNebojša Pavlović ; Karmen Stankov ; Momir Mikov 
1291-јан-2014Probucol Release from Novel Multicompartmental Microcapsules for the Oral Targeted Delivery in Type 2 DiabetesMooranian A.; Negrulj R.; Al-Sallami H.; Fang Z.; Momir Mikov ; Svetlana Goločorbin-Kon ; Fakhoury M.; Watts G.; Matthews V.; Arfuso F.; Lambros A.; Al-Salami H.
1301-јан-2019Probucol-poly(meth)acrylate-bile acid nanoparticles increase IL-10, and primary bile acids in prediabetic miceMooranian A.; Zamani N.; Takechi R.; Al-Sallami H.; Momir Mikov ; Svetlana Goločorbin-Kon ; Božica Kovačević; Arfuso F.; Al-Salami H.
1311-апр-2009Protective effects of celery juice in treatments with doxorubicinJovanka Kolarović ; Mira Popović; Momir Mikov ; Radoslav Mitić; Ljiljana Gvozdenović 
1321-окт-2011The protective effects of silymarin against doxorubicin-induced cardiotoxicity and hepatotoxicity in ratsAleksandar Rašković ; Nebojša Stilinović ; Jovanka Kolarović ; Velibor Vasović ; Saša Vukmirović ; Momir Mikov 
1331-дец-2019Rapid, trace-level direct cathodic voltammetric determination of dopamine by oxidized multiwalled carbon nanotube–modified carbon paste electrode in selected samples of pharmaceutical importanceJasmina Anojčić; Valerija (Valéria) Guzvanj (Guzsvány) ; Zoltan Kónya; Momir Mikov 
1341-феб-2018The relationship between tacrolimus concentration-dose ratio and genetic polymorphism in patients subjected to renal transplantationRančić N.; Vavić N.; Cikota-Aleksić B.; Magić Z.; Momir Mikov ; Bokonjić D.; Šegrt Z.; Dragojević-Simić V.
1351-јан-2015Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatmentMooranian A.; Negrulj R.; Al-Sallami H.; Fang Z.; Momir Mikov ; Svetlana Goločorbin-Kon ; Fakhoury M.; Aruso F.; Al-Salami H.
13620-сеп-2016Retention data of bile acids and their oxo derivatives in characterization of pharmacokinetic properties and in silico ADME modelingJovana Trifunović; Vladan Borčić; Saša Vukmirović ; Svetlana Goločorbin-Kon ; Momir Mikov 
1371-дец-2017The Role of Drug Metabolites in the Inhibition of Cytochrome P450 EnzymesMomir Mikov ; Maja Đanić ; Nebojša Pavlović ; Bojan Stanimirov ; Svetlana Goločorbin-Kon ; Karmen Stankov ; Hani Al-Salami
1387-дец-2019A second-generation micro/nano capsules of an endogenous primary un-metabolised bile acid, stabilized by Eudragit-alginate complex with antioxidant compoundsArmin Mooranian; Nassim Zamani; Momir Mikov ; Svetlana Goločorbin-Kon ; Goran Stojanović ; Frank Arfuso; Božica Kovačević; Hani Al-Salami
1392019Semisynthetic bile acids: a new therapeutic option for metabolic syndromeLazarević, Slavica; Đanić, Maja ; Goločorbin-Kon, Svetlana ; Al-Salami, Hani; Mikov, Momir 
1401-феб-2019Stability and biological testing of taurine-conjugated bile acid antioxidant microcapsules for diabetes treatmentMooranian A.; Zamani N.; Momir Mikov ; Svetlana Goločorbin-Kon ; Goran Stojanović ; Arfuso F.; Al-Salami H.